Literature DB >> 17114572

Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.

Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Francesco Di Raimondo, Lucio Catalano, Alfonso D'Arco, Sonia Ronconi, Claudia Cellini, Massimo Offidani, Giulia Perrone, Michela Ceccolini, Annamaria Brioli, Sante Tura, Michele Baccarani, Michele Cavo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114572     DOI： 10.1182/blood-2006-07-033571

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  19 in total

Review 1.  Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Authors:  Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Cochrane Database Syst Rev       Date:  2017-12-18

2.  Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.

Authors:  Christian Walter; Bilal Al-Nawas; Norbert Frickhofen; Heinold Gamm; Joachim Beck; Laura Reinsch; Christina Blum; Knut A Grötz; Wilfried Wagner
Journal:  Head Face Med       Date:  2010-07-08       Impact factor: 2.151

3.  Prevention of bisphosphonates-induced osteonecrosis.

Authors:  Anna Baraldi; Vittorio Fusco; Alessandro Bellora; Massimo Pini
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

4.  Osteonecrosis of the myeloma patients treated with bisphosphonates.

Authors:  Silvana Capalbo; Maria Grazia Franzese; Gaetano Palumbo
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

Review 5.  Potential pathophysiological mechanisms in osteonecrosis of the jaw.

Authors:  Regina Landesberg; Victoria Woo; Serge Cremers; Matthew Cozin; Darja Marolt; Gordana Vunjak-Novakovic; Stavroula Kousteni; Srikala Raghavan
Journal:  Ann N Y Acad Sci       Date:  2011-02       Impact factor: 5.691

6.  Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Rebecca Anne Miksad; Kuan-Chi Lai; Thomas Benton Dodson; Sook-Bin Woo; Nathaniel Simon Treister; Omosalewa Akinyemi; Marian Bihrle; Guy Maytal; Meredith August; G Scott Gazelle; J Shannon Swan
Journal:  Oncologist       Date:  2011-01-06

Review 7.  [Bisphosphonate-associated osteonecrosis of the jaw].

Authors:  Maria-Theresa Krauth; Alexander Fügl; Reinhard Gruber
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 8.  ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.

Authors:  Franco Dammacco; Giuseppe Rubini; Cristina Ferrari; Angelo Vacca; Vito Racanelli
Journal:  Clin Exp Med       Date:  2014-09-14       Impact factor: 3.984

Review 9.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616

10.  Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.

Authors:  Alberto Borgioli; Christian Viviani; Marco Duvina; Leila Brancato; Giuseppe Spinelli; Maria Luisa Brandi; Paolo Tonelli
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.